aluates Reports

$ 0.0

Automative

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Othe-477

Global Stem Cell Umbilical Cord Blood Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

Code: QYRE-Othe-477

Report

September 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advanced Cell Technology

California Stem Cell

Mesoblast Limited

Opexa Therapeutics

Athersys

Geron Corporation

Neostem

Cytori Therapeutics

Stem Cell Umbilical Cord Blood Market Size

The global market for Stem Cell Umbilical Cord Blood was valued at US$ 32860 million in the year 2024 and is projected to reach a revised size of US$ 212430 million by 2031, growing at a CAGR of 31.0% during the forecast period.

Stem Cell Umbilical Cord Blood Market

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Stem Cell Umbilical Cord Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Umbilical Cord Blood.

The Stem Cell Umbilical Cord Blood market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Umbilical Cord Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stem Cell Umbilical Cord Blood companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Stem Cell Umbilical Cord Blood Market Report

Report Metric	Details
Report Name	Stem Cell Umbilical Cord Blood Market
Accounted market size in year	US$ 32860 million
Forecasted market size in 2031	US$ 212430 million
CAGR	31.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Public Cord Blood Banks Private Cord Blood Banks
Segment by Application	Cancer/ Oncology Diseases Chronic Leukemia Myelodysplastic Syndrome Blood Diseases Beta Thalassemia Sickle Cell Disease Wiskott-Aldrich Hurler Syndrome Sanfilippo Syndrome
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation, Neostem
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Umbilical Cord Blood company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Stem Cell Umbilical Cord Blood Market growing?

Ans: The Stem Cell Umbilical Cord Blood Market witnessing a CAGR of 31.0% during the forecast period 2025-2031.

What is the Stem Cell Umbilical Cord Blood Market size in 2031?

Ans: The Stem Cell Umbilical Cord Blood Market size in 2031 will be US$ 212430 million.

Who are the main players in the Stem Cell Umbilical Cord Blood Market report?

Ans: The main players in the Stem Cell Umbilical Cord Blood Market are Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation, Neostem

What are the Application segmentation covered in the Stem Cell Umbilical Cord Blood Market report?

Ans: The Applications covered in the Stem Cell Umbilical Cord Blood Market report are Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome, Blood Diseases, Beta Thalassemia, Sickle Cell Disease, Wiskott-Aldrich, Hurler Syndrome, Sanfilippo Syndrome

What are the Type segmentation covered in the Stem Cell Umbilical Cord Blood Market report?

Ans: The Types covered in the Stem Cell Umbilical Cord Blood Market report are Public Cord Blood Banks, Private Cord Blood Banks

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Public Cord Blood Banks

1.2.3 Private Cord Blood Banks

1.3 Market by Application

1.3.1 Global Stem Cell Umbilical Cord Blood Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer/ Oncology Diseases

1.3.3 Chronic Leukemia

1.3.4 Myelodysplastic Syndrome

1.3.5 Blood Diseases

1.3.6 Beta Thalassemia

1.3.7 Sickle Cell Disease

1.3.8 Wiskott-Aldrich

1.3.9 Hurler Syndrome

1.3.10 Sanfilippo Syndrome

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Stem Cell Umbilical Cord Blood Market Perspective (2020-2031)

2.2 Global Stem Cell Umbilical Cord Blood Growth Trends by Region

2.2.1 Global Stem Cell Umbilical Cord Blood Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Stem Cell Umbilical Cord Blood Historic Market Size by Region (2020-2025)

2.2.3 Stem Cell Umbilical Cord Blood Forecasted Market Size by Region (2026-2031)

2.3 Stem Cell Umbilical Cord Blood Market Dynamics

2.3.1 Stem Cell Umbilical Cord Blood Industry Trends

2.3.2 Stem Cell Umbilical Cord Blood Market Drivers

2.3.3 Stem Cell Umbilical Cord Blood Market Challenges

2.3.4 Stem Cell Umbilical Cord Blood Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue

3.1.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue (2020-2025)

3.1.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Players (2020-2025)

3.2 Global Stem Cell Umbilical Cord Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Stem Cell Umbilical Cord Blood Revenue

3.4 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio

3.4.1 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Umbilical Cord Blood Revenue in 2024

3.5 Global Key Players of Stem Cell Umbilical Cord Blood Head office and Area Served

3.6 Global Key Players of Stem Cell Umbilical Cord Blood, Product and Application

3.7 Global Key Players of Stem Cell Umbilical Cord Blood, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell Umbilical Cord Blood Breakdown Data by Type

4.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Type (2020-2025)

4.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2026-2031)

5 Stem Cell Umbilical Cord Blood Breakdown Data by Application

5.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Application (2020-2025)

5.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Stem Cell Umbilical Cord Blood Market Size (2020-2031)

6.2 North America Stem Cell Umbilical Cord Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025)

6.4 North America Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Stem Cell Umbilical Cord Blood Market Size (2020-2031)

7.2 Europe Stem Cell Umbilical Cord Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025)

7.4 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size (2020-2031)

8.2 Asia-Pacific Stem Cell Umbilical Cord Blood Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2020-2025)

8.4 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Stem Cell Umbilical Cord Blood Market Size (2020-2031)

9.2 Latin America Stem Cell Umbilical Cord Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025)

9.4 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size (2020-2031)

10.2 Middle East & Africa Stem Cell Umbilical Cord Blood Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025)

10.4 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Advanced Cell Technology

11.1.1 Advanced Cell Technology Company Details

11.1.2 Advanced Cell Technology Business Overview

11.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Introduction

11.1.4 Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.1.5 Advanced Cell Technology Recent Development

11.2 California Stem Cell

11.2.1 California Stem Cell Company Details

11.2.2 California Stem Cell Business Overview

11.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Introduction

11.2.4 California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.2.5 California Stem Cell Recent Development

11.3 Cytori Therapeutics

11.3.1 Cytori Therapeutics Company Details

11.3.2 Cytori Therapeutics Business Overview

11.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Introduction

11.3.4 Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.3.5 Cytori Therapeutics Recent Development

11.4 Mesoblast Limited

11.4.1 Mesoblast Limited Company Details

11.4.2 Mesoblast Limited Business Overview

11.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Introduction

11.4.4 Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.4.5 Mesoblast Limited Recent Development

11.5 Opexa Therapeutics

11.5.1 Opexa Therapeutics Company Details

11.5.2 Opexa Therapeutics Business Overview

11.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Introduction

11.5.4 Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.5.5 Opexa Therapeutics Recent Development

11.6 Athersys

11.6.1 Athersys Company Details

11.6.2 Athersys Business Overview

11.6.3 Athersys Stem Cell Umbilical Cord Blood Introduction

11.6.4 Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.6.5 Athersys Recent Development

11.7 Geron Corporation

11.7.1 Geron Corporation Company Details

11.7.2 Geron Corporation Business Overview

11.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Introduction

11.7.4 Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.7.5 Geron Corporation Recent Development

11.8 Neostem

11.8.1 Neostem Company Details

11.8.2 Neostem Business Overview

11.8.3 Neostem Stem Cell Umbilical Cord Blood Introduction

11.8.4 Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025)

11.8.5 Neostem Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Advanced Cell Technology

California Stem Cell

Mesoblast Limited

Opexa Therapeutics

Athersys

Geron Corporation

Neostem

Cytori Therapeutics

List of Tables

Table 1. Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Public Cord Blood Banks

Table 3. Key Players of Private Cord Blood Banks

Table 4. Global Stem Cell Umbilical Cord Blood Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Stem Cell Umbilical Cord Blood Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Stem Cell Umbilical Cord Blood Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Stem Cell Umbilical Cord Blood Market Share by Region (2020-2025)

Table 8. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Stem Cell Umbilical Cord Blood Market Share by Region (2026-2031)

Table 10. Stem Cell Umbilical Cord Blood Market Trends

Table 11. Stem Cell Umbilical Cord Blood Market Drivers

Table 12. Stem Cell Umbilical Cord Blood Market Challenges

Table 13. Stem Cell Umbilical Cord Blood Market Restraints

Table 14. Global Stem Cell Umbilical Cord Blood Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Stem Cell Umbilical Cord Blood Market Share by Players (2020-2025)

Table 16. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2024)

Table 17. Ranking of Global Top Stem Cell Umbilical Cord Blood Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Stem Cell Umbilical Cord Blood Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Stem Cell Umbilical Cord Blood, Headquarters and Area Served

Table 20. Global Key Players of Stem Cell Umbilical Cord Blood, Product and Application

Table 21. Global Key Players of Stem Cell Umbilical Cord Blood, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Stem Cell Umbilical Cord Blood Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Type (2020-2025)

Table 25. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Type (2026-2031)

Table 27. Global Stem Cell Umbilical Cord Blood Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2020-2025)

Table 29. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2026-2031)

Table 31. North America Stem Cell Umbilical Cord Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Stem Cell Umbilical Cord Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Stem Cell Umbilical Cord Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2026-2031) & (US$ Million)

Table 46. Advanced Cell Technology Company Details

Table 47. Advanced Cell Technology Business Overview

Table 48. Advanced Cell Technology Stem Cell Umbilical Cord Blood Product

Table 49. Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 50. Advanced Cell Technology Recent Development

Table 51. California Stem Cell Company Details

Table 52. California Stem Cell Business Overview

Table 53. California Stem Cell Stem Cell Umbilical Cord Blood Product

Table 54. California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 55. California Stem Cell Recent Development

Table 56. Cytori Therapeutics Company Details

Table 57. Cytori Therapeutics Business Overview

Table 58. Cytori Therapeutics Stem Cell Umbilical Cord Blood Product

Table 59. Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 60. Cytori Therapeutics Recent Development

Table 61. Mesoblast Limited Company Details

Table 62. Mesoblast Limited Business Overview

Table 63. Mesoblast Limited Stem Cell Umbilical Cord Blood Product

Table 64. Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 65. Mesoblast Limited Recent Development

Table 66. Opexa Therapeutics Company Details

Table 67. Opexa Therapeutics Business Overview

Table 68. Opexa Therapeutics Stem Cell Umbilical Cord Blood Product

Table 69. Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 70. Opexa Therapeutics Recent Development

Table 71. Athersys Company Details

Table 72. Athersys Business Overview

Table 73. Athersys Stem Cell Umbilical Cord Blood Product

Table 74. Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 75. Athersys Recent Development

Table 76. Geron Corporation Company Details

Table 77. Geron Corporation Business Overview

Table 78. Geron Corporation Stem Cell Umbilical Cord Blood Product

Table 79. Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 80. Geron Corporation Recent Development

Table 81. Neostem Company Details

Table 82. Neostem Business Overview

Table 83. Neostem Stem Cell Umbilical Cord Blood Product

Table 84. Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2020-2025) & (US$ Million)

Table 85. Neostem Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Stem Cell Umbilical Cord Blood Picture

Figure 2. Global Stem Cell Umbilical Cord Blood Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Stem Cell Umbilical Cord Blood Market Share by Type: 2024 VS 2031

Figure 4. Public Cord Blood Banks Features

Figure 5. Private Cord Blood Banks Features

Figure 6. Global Stem Cell Umbilical Cord Blood Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Stem Cell Umbilical Cord Blood Market Share by Application: 2024 VS 2031

Figure 8. Cancer/ Oncology Diseases Case Studies

Figure 9. Chronic Leukemia Case Studies

Figure 10. Myelodysplastic Syndrome Case Studies

Figure 11. Blood Diseases Case Studies

Figure 12. Beta Thalassemia Case Studies

Figure 13. Sickle Cell Disease Case Studies

Figure 14. Wiskott-Aldrich Case Studies

Figure 15. Hurler Syndrome Case Studies

Figure 16. Sanfilippo Syndrome Case Studies

Figure 17. Stem Cell Umbilical Cord Blood Report Years Considered

Figure 18. Global Stem Cell Umbilical Cord Blood Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Stem Cell Umbilical Cord Blood Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Stem Cell Umbilical Cord Blood Market Share by Region: 2024 VS 2031

Figure 21. Global Stem Cell Umbilical Cord Blood Market Share by Players in 2024

Figure 22. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Stem Cell Umbilical Cord Blood Revenue in 2024

Figure 24. North America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Stem Cell Umbilical Cord Blood Market Share by Country (2020-2031)

Figure 26. United States Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Stem Cell Umbilical Cord Blood Market Share by Country (2020-2031)

Figure 30. Germany Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Stem Cell Umbilical Cord Blood Market Share by Region (2020-2031)

Figure 38. China Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Stem Cell Umbilical Cord Blood Market Share by Country (2020-2031)

Figure 46. Mexico Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Stem Cell Umbilical Cord Blood Market Share by Country (2020-2031)

Figure 50. Turkey Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Stem Cell Umbilical Cord Blood Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Advanced Cell Technology Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 54. California Stem Cell Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 55. Cytori Therapeutics Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 56. Mesoblast Limited Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 57. Opexa Therapeutics Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 58. Athersys Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 59. Geron Corporation Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 60. Neostem Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions